Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1Roudebush VA Medical Center, Indiana University School of Medicine, Indianapolis, IN, USA; 2College of Applied Behavioral Sciences, University of Indianapolis, Indianapolis, IN, USA; 3Indiana University School of Medicine, Eskenazi Health-Midtown Community Mental Health, Indianapolis, IN, USA; 4Wesleyan University, Middletown, CT, USA; 5Indiana University School of Medicine, Indianapolis, IN, USA
Список исп. литературыСкрыть список
1. Pick A. Uber Krankheitsbewusstsein in psychischen Krankheiten. Arch Psychiatr Nervenkr 1882;13:518-81.
2. Lewis A. The psychopathology of insight. Br J Med Psychol 1934;14:332-48.
3. Weinstein EA, Robert LK. Denial of illness: symbolic and physiological aspects. Springfield: Thomas, 1955.
4. Phelps S. Blind to their blindness: a history of the denial of illness. PhD Dissertation, Harvard University, Boston, 2014.
5. Kane JM. Improving patient outcomes in schizophrenia: achieving remission, preventing relapse, and measuring success. J Clin Psychiatry 2013;74:e18.
6. Schennach R, Meyer S, Seemuller F et al. Insight in schizophrenia course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder. Eur Psychiatry 2012;27: 625-33.
7. Wang Y, Xiang YT, Wang CY et al. Insight in Chinese schizophrenia patients: a 12-month follow-up. J Psychiatr Ment Health Nurs 2011;18:751-7.
8. Cuesta MJ, Peralta V, Campos MS et al. Can insight be predicted in first episode psychosis patients? A longitudinal and hierarchical analysis of predictors in a drug-naıve sample. Schizophr Res 2011;130:148-56.
9. Koren D, Viksman P, Giuliano AJ et al. The nature and evolution of insight in schizophrenia: a multi-informant longitudinal study of first-episode versus chronic patients. Schizophr Res 2013;151:245-51.
10. Osatuke K, Ciesla J, Kasckow JW et al. Insight in schizophrenia: a review of etiological models and supporting research. Compr Psychiatry 2008;49:70-7.
11. Vohs JL, Lysaker PH, Liffick E et al. Metacognitive capacity as a predictor of insight in first-episode psychosis. J Nerv Ment Dis 2015;203:372-8.
12. Braw Y, Sitman R, Sela T et al. Comparison of insight among schizophrenia and bipolar disorder patients in remission of affective and positive symptoms: analysis and critique. Eur Psychiatry 2012;27:612-8.
13. Lysaker PH, Vohs J, Hillis JD et al. Poor insight into schizophrenia: contributing factors, consequences, and emerging treatment approaches. Expert Rev Neurother 2013;13:785-93.
14. Amador XF, Flaum M, Andreasen NC et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry1994;51:826-36.
15. Martin JM, Warman DM, Lysaker PH. Cognitive insight in non-psychiatric individuals and individuals with psychosis: an examination using the Beck Cognitive Insight Scale. Schizophr Res 2010;121:39-45.
16. Riggs SE, Grant PM, Perivoliotis D et al. Assessment of cognitive insight: a qualitative review. Schizophr Bull 2012;38:338-50.
17. Lincoln TM, Lullman E, Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr Bull 2007;33:1324-42.
18. Misdrahi D, Tessier A, Swendesen J et al. Determination of adherence profiles in schizophrenia using self-reported adherence: results from the FACE-SZ dataset. J Clin Psychiatry 2016;77:1130-6.
19. Lincoln TM, Jung E, Wiesiahn M et al. The impact of negative treatment experiences on persistent refusal of antipsychotics. Compr Psychiatry 2016;70:165-73.
20. Chan KW, Hui LM, Wong HY et al. Medication adherence, knowledge about psychosis, and insight among patients with a schizophrenia spectrum disorder. J Nerv Ment Dis 2014;202:25-9.
21. Chandra IS, Kumar KL, Reddy MP et al. Attitudes toward medication andreasons for non-compliance in patients with schizophrenia. Indian J Psychol Med 2014;36:294-8.
22. Eticha T, Teklu A, Ali D et al. Factors associated with medication adherenceamong patients with schizophrenia in Mekelle, Northern Ethiopia. PLoS One 2015;10:1-11.
23. Na E, Yim SJ, Lee JN et al. Relationships among medication adherence, insight, and neurocognition in chronic schizophrenia. Psychiatry Clin Neurosci 2015;69:298-304.
24. Hui CL, Lau WW, Leung CM et al. Clinical and social correlates of durationof untreated psychosis among adult-onset psychosis in Hong Kong Chinese: the JCEP study. Early Interv Psychiatry 2015;9:118-25.
25. O’Donoghue B, Lyne J, Kinsella A et al. Detection and characteristics of individuals with a very long duration of untreated psychosis in anearly intervention for psychosis service. Early Interv Psychiatry 2014;8:332-9.
26. Karthik MS, Warikoo N, Chakrabarti S et al. Attitudes towards antipsychoticsamong patients with schizophrenia on first- or second-generation medications. Indian J Psychol Med 2014;36:288-93.
27. Samalin L, de Chazeron I, Blanc O et al. Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherencein schizophrenia. Schizophr Res 2016;178:1-5.
28. Ramachandran AS, Ramanathan R, Praharai SK et al. A cross-sectional, comparative study of insight in schizophrenia and bipolar patients inremission. Indian J Psychol Med 2016;38:207-12.
29. Kako Y, Ito K, Hashimoto N et al. The relationship between insight and subjective experience in schizophrenia. Neuropsychiatr Dis Treat 2014;10:1415-22.
30. Zhou J, Xiang YT, Li Q et al. Gender differences in attitudes towards antipsychotic medications in patients with schizophrenia. Psychiatry Res2016;245:276-81.
31. Zhou Y, Rosenheck R, Mohamed S et al. Factors associated with completed is continuation of medication among patients with schizophrenia in the year after hospital discharge. Psychiatry Res 2017;250:129-35.
32. Czobor P, Van Dorn RA, Citrome L et al. Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies. Eur Neuropsychopharmacol 2015;25:1158-66.
33. Abdel Aziz K, Elamin MH, El-Saadouni NM et al. Schizophrenia: impact of psychopathology, faith healers and psycho-education on adherence tomedication. Int J Soc Psychiatry 2016;62:719-25.
34. Siu CO, Harvey PD, Agid O et al. Insight and subjective measures ofquality of life in chronic schizophrenia. Schizophr Res Cogn 2015;2:127-32.
35. Noordraven EL, Wierdsma AI, Blanken P et al. Depot-medication compliance for patients with psychotic disorders: the importance of illness insightand treatment motivation. Neuropsychiatr Dis Treat 2016;12:269-74.
36. Velligan DI, Sajatovic M, Hatch A et al. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for non-adherence to medication in patients with serious mental illness. Patient Prefer Adherence 2017;11:449-68.
37. Lincoln TM, Rief W, Westermann S et al. Who stays, who benefits? Predicting dropout and change in cognitive behaviour therapy for psychosis. Psychiatry Res 2014;216:198-205.
38. Berry K, Gregg L, Lobban F et al. Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Compr Psychiatry 2016;67:73-80.
39. Cavelti M, Rusch N, Vauth R. Is living with psychosis demoralizing? Insight, self-stigma, and clinical outcome among people with schizophrenia across 1 year. J Nerv Ment Dis 2014;202:521-9.
40. Ruchlewska A, Kamperman AM, van der Gaag M et al. Working alliance in patients with severe mental illness who need a crisis intervention plan. Community Ment Health J 2016;52:102-8.
41. Bo B, Ottesen OH, Gjestad R et al. Patient satisfaction after acute admission for psychosis. Nord J Psychiatry 2016;70:321-8.
42. Mintz AR, Dobson KS, Romney DM. Insight in schizophrenia: a metaanalysis. Schizophr Res 2003;61:75-88.
43. Johnson S, Sathyaseelan M, Charles H et al. Predictors of disability: a 5-year cohort study of first-episode schizophrenia. Asian J Psychiatry 2014;9:45-50.
44. Bianchini O, Porcelli S, Nespeca C et al. Effects on antipsychotic drugs on insight in schizophrenia. Psychiatry Res 2014;218:20-4.
45. Kumar A, Sharma P, Das S et al. Insight in psychotic disorder: relation with psychopathology and frontal lobe function. Psychopathology 2014;47:32-8.
46. Pousa E, Ochoa S, Cobo J et al. A deeper view of insight in schizophrenia: insight dimensions, unawareness and misattribution of particular symptoms and its relation with psychopathological factors. Schizophr Res 2017;189:61-8.
47. Zhou Y, Rosenheck R, Mohamed S et al. Insight in inpatients with schizophrenia: relationship to symptoms and neuropsychological functioning. Schizophr Res 2015;161:376-81.
48. Chan KK. Associations of symptoms, neurocognition, and metacognition with insight in schizophrenia spectrum disorders. Compr Psychiatry 2016;65:63-9.
49. Chang WC, Lau CF, Chan SS et al. Premorbid, clinical and cognitive correlates of primary negative symptoms in first-episode psychosis. Psychiatry Res 2016;242:144-9.
50. Nestsiarovich A, Obyedkov V, Kandratsenka H et al. Disorganization at the stage of schizophrenia clinical outcome: clinical-biological study. Eur Psychiatry 2016;42:44-8.
51. Sanchez-Torres AM, Zarzuela A, Peralta V et al. The association of lifetime insight and cognition in psychosis. Schizophr Res 2015;162:183-8.
52. Yanos PT, Vavshenker B, Pleskach P et al. Insight among people with severe mental illness, co-occurring PTSD and elevated psychotic symptoms: correlates and relationship to treatment participation. Compr Psychiatry 2016;68:172-7.
53. Volavka J, Van Dorn RA, Citrome L et al. Hostility in schizophrenia: an integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies. Eur Psychiatry 2016;31:13-9.
54. Berge D, Mane A, Salgado P et al. Predictors of relapse and functioning in first-episode psychosis: a two-year follow-up study. Psychiatry Serv 2016;67:227-33.
55. Gumley AI, Schwannauer M, Macbeth A et al. Insight, duration of untreated psychosis and attachment in first-episode psychosis: prospective study of psychiatric recovery over 12-month follow-up. Br J Psychiatry 2014;205: 60-7.
56. Misiak B, Frydecka D, Beszlei JA et al. Effects of antipsychotics on insight in schizophrenia: results from independent samples of first-episode and acute relapsed patients. Int Clin Psychopharmacol 2016;31:185-91.
57. Quee PJ, van der Meer L, Krabbendam L et al. Insight change in psychosis: relationship with neurocognition, social cognition, clinical symptoms, and phase of illness. Acta Psychiatr Scand 2014;129:126-33.
58. Chan SK, Chan KK, Hui CL et al. Correlates of insight with symptomatology and executive function in patients with first-episode schizophrenia-spectrum disorder: a longitudinal perspective. Psychiatry Res 2014;216:177-84.
59. Cobo J, Nieto L, Ochoa S et al. Insight and gender in schizophrenia and other psychoses. Psychiatry Res 2016;243:268-77.
60. Kimhy D, Jobson-Ahmed L, Ben-David S et al. Cognitive insight in individuals at clinical high risk for psychosis. Early Interv Psychiatry 2014;8:130-7.
61. Uchida T, Matsumoto K, Ito F et al. Relationship between cognitive insight and attenuated delusional symptoms in individuals with at-risk mental state. Psychiatry Res 2014;217:20-4.
62. O’Connor JA, Ellett L, Ainakina O et al. Can cognitive insight predict symptom remission in a first episode psychosis cohort? BMC Psychiatry 2017;17:54.
63. Benoit A, Harvey PO, Bherer L et al. Does the Beck Cognitive Insight Scale predict response to cognitive remediation in schizophrenia? Schizophr Res Treatment 2016;2016:6371856.
64. Zhang Q, Li X, Parker GJ et al. Theory of mind correlates with clinical insight but not cognitive insight in patients with schizophrenia. Psychiatry Res 2016;237:188-95.
65. Erol A, Delibas H, Bora O et al. The impact of insight on social functioning in patients with schizophrenia. Int J Soc Psychiatry 2015;61:379-85.
66. Firmin RL, Luther L, Lysaker PH et al. Self-initiated helping behaviors and recovery in severe mental illness: implications for work, volunteerism, and peer support. Psychiatr Rehabil J 2015;38:336-41.
67. Montemagni C, Castagna F, Crivelli B et al. Relative contributions of negative symptoms, insight, and coping strategies to quality of life in stable schizophrenia. Psychiatry Res 2014;220:102-11.
68. Tastet H, Verdoux H, Bouisson J et al. Impact of interpersonal factors on insight in schizophrenia. Schizophr Res 2014;159:527-32.
69. Morandi S, Golay P, Lambert M et al. Community treatment order: identifying the need for more evidence based justification of its use in first episode psychosis patients. Schizophr Res 2016;185:67-72.
70. Drake RJ, Nordentoft M, Haddock G et al. Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention. Schizophr Bull 2015;41:584-96.
71. Chong CS, Siu MW, Kwan CH et al. Predictors of functioning in people suffering from first-episode psychosis 1 year into entering early interventions service in Hong Kong. Early Interv Psychiatry (in press).
72. Cannayo D, Minutolo G, Battaglia E et al. Insight and recovery in schizophrenic patients. Int J Psychiatry ClinPract 2016;20:83-90.
73. Klaas HS, Clemence A, Marion-Veyron R et al. Insight as a social identity process in the evolution of psychosocial functioning in the early phase of psychosis. Psychol Med 2017;47:718-29.
74. Ayesa-Arriola R, Moriñigo JD, David AS et al. Lack of insight 3 years after first-episode psychosis: an unchangeable illness trait determined from first presentation? Schizophr Res 2014;157:271-7.
75. Lysaker PH, Roe D, Yanos PT. Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophr Bull 2007;33:192-9.
76. Onwuameze OE, Uga A, Paradiso S. Longitudinal assessment of clinical risk factors for depression in schizophrenia spectrum disorders. Ann Clin Psychiatry 2016;28:167-74.
77. Misdrahi D, Denard S, Swendsen J et al. Depression in schizophrenia: the influence of the different dimensions of insight. Psychiatry Res 2014;216:6-12.
78. Rossi A, Amore M, Galderisi S et al. The complex relationship between self-reported ‘personal recovery’ and clinical recovery in schizophrenia. Schizophr Res (in press).
79. Thomas N, Ribaux D, Phillips LJ. Rumination, depressive symptoms and awareness of illness in schizophrenia. Behav Cogn Psychother 2014;42:1-13.
80. Margariti M, Ploumpidis D, Economou M et al. Quality of life in schizophrenia spectrum disorders: association with insight and psychopathology. Psychiatry Res 2015;225:695-701.
81. Schrank B, Amering M, Hay AG et al. Insight, positive and negative symptoms, hope, depression and self-stigma: a comprehensive model of mutual influences in schizophrenia spectrum disorders. Epidemiol Psychiatr Sci 2014;23:271-9.
82. Belvederi Murri M, Amore M, Calcagno P et al. The “insight paradox” in schizophrenia: magnitude, moderators and mediators of the association between insight and depression. Schizophr Bull 2016;42:1225-33.
83. Lien YJ, Chang HA, Kao YC et al. Insight, self-stigma and psychosocial outcomes in schizophrenia: a structural equation modeling approach. Epidemiol Psychiatr Sci 2016;15:1-10.
84. Valiente C, Provencio M, Espinosa R et al. Insight in paranoia: the role of experiential avoidance and internalized stigma. Schizophr Res 2015;164:214-20.
85. MacDougall AG, Vandermeer MR, Norman RM. Negative future self as a mediator in the relationship between insight and depression in psychotic disorders. Schizophr Res 2015;165:66-9.
86. Grover S, Sahoo S, Nehra R et al. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia. Int J Soc Psychiatry 2017;6:181-94.
87. Belvederi Murri M, Respino M, Innamorati M et al. Is good insight associated with depression among patients with schizophrenia? Systematicreview and meta-analysis. Schizophr Res 2015;162:234-47.
88. Buck KD, Roe D, Yanos PT et al. Challenges to assisting with the recovery of personal identity and wellness for persons with serious mental illness: considerations for mental health professionals. Psychosis 2013;5:127-33.
89. Giusti L, Ussorio D, Tosone A et al. Is personal recovery in schizophrenia predicted by low cognitive insight? Community Ment Health J 2015;51:30-7.
90. Kim JH, Lee S, Han AY et al. Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia. Neuropsychiatr Dis Treat 2015;11:2041-8.
91. Phalen PL, Viswanadhan K, Lysaker PH et al. The relationship between cognitive insight and quality of life in schizophrenia spectrum disorders: symptom severity as potential moderator. Psychiatry Res 2015;230:839-45.
92. Palmer EC, Gilleen J, David AS. The relationship between cognitive insight and depression in psychosis and schizophrenia: a review and meta-analysis. Schizophr Res 2015;166:261-8.
93. Weintraub MJ, Weismann de Mamani A. Effects of sub-clinical psychosis and cognitive insight on psychological well-being: a structural equation model. Psychiatry Res 2015;226:149-55.
94. Adan A, Capella MD, Prat G et al. Executive functioning in men with schizophrenia and substance use disorders: influence of lifetime suicide attempts. PLoS One 2017;12:1-16.
95. Lopez-Moriñigo JD, Wiffen B, O’Connor J et al. Insight and suicidality in first-episode psychosis: understanding the influence of suicidal history on insight dimensions at first presentation. Early Interv Psychiatry 2014;8:113-21.
96. Barrett EA, Mork E, Faerden A et al. The development of insight and its relationship with suicidality over one year follow-up in patients with first episode psychosis. Schizophr Res 2015;162:97-102.
97. Massons C, Lopez-Moriñigo JD, Pousa E et al. Insight and suicidality in psychosis: a cross-sectional study. Psychiatry Res 2017;252:147-53.
98. Henriksen MG, Parnas J. Self-disorders and schizophrenia: a phenomenological reappraisal of poor insight and noncompliance. Schizophr Bull 2014;40:542-7.
99. Xavier RM, Vorderstrasse A. Neurobiological basis of insight in schizophrenia: a systematic review. Nurs Res 2016;65:224-37.
100. Asmal L, du Plessis S, Vink M et al. Insight and white matter fractional anisotropy in first-episode psychosis. Schizophr Res 2016;183:88-94.
101. Chen X, Duan M, He H et al. Functional abnormalities of the right posterior insula are related to the altered self-experience in schizophrenia. Psychiatry Res 2016;256:26-32.
102. Gerretsen P, Menon M, Mamo DC et al. Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders: resting state functional connectivity. Schizophr Res 2014;160:43-50.
103. Lee JS, Chun JW, Lee SH et al. Altered neural basis of the reality processing and its relation to cognitive insight in schizophrenia. PLoS One 2015;10:1-15.
104. Shad MU, Keshayan MS. Neurobiology of insight deficits in schizophrenia: an fMRI study. Schizophr Res 2015;165:220-6.
105. Zhang L, Opmeet EM, Ruhe HG et al. Brain activation during self- and other-reflection in bipolar disorder with a history of psychosis: comparison to schizophrenia. Neuroimage Clin 2015;8:202-9.
106. Larabi DI, Liemburg EJ, Pijnenborg GH et al. Association between prefrontal N-acetylaspartate and insight in psychotic disorders. Schizophr Res 2017;179:112-8.
107. Sapara A, Ftytche DH, Cooke MA et al. Voxel-based magnetic resonance imaging investigation of poor and preserved clinical insight in people with schizophrenia. World J Psychiatry 2016;6:311-21.
108. Emami S, Guimond S, Mallar Chakravarty M et al. Cortical thickness and low insight into symptoms in enduring schizophrenia. Schizophr Res 2016;170:66-72.
109. Parellada M, Pina-Camacho L, Moreno C et al. Insular pathology in young people with high-functioning autism and first-episode psychosis. Psychol Med 2017;47:2472-82.
110. Buchy L, Barbato M, MacMaster FP et al. Cognitive insight is associated with cortical thickness in first-episode psychosis. Schizophr Res 2016;172:16-22.
111. Curcic-Blake B, van der Meer L, Pijnenborg GH et al. Insight and psychosis: functional and anatomical brain connectivity and self-reflection in schizophrenia. Hum Brain Mapp 2015;36:4859-68.
112. Kuang C, Buchy L, Barbato M et al. A pilot study of cognitive insight and structural covariance in first-episode psychosis. Schizophr Res 2017;179:91-6.
113. Shenton ME, Whitford TJ, Kubicki M. Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci 2010;12:317-32.
114. Berge DS, Carmona M, Rovira A et al. Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic episode subjects. Acta Psychiatr Scand 2011;123: 431-9.
115. Buchy L, Hawco C, Joober R et al. Cognitive insight in first-episode schizophrenia: further evidence for a role of the ventrolateral prefrontal cortex. Schizophr Res 2015;166:65-8.
116. Sapara A, Ffytche DH, Birchwood M et al. Preservation and compensation: the functional neuroanatomy of insight and working memory in schizophrenia. Schizophr Res 2014;152:201-9.
117. Sapara A, Ffytche DH, Cooke MA et al. Is it me? Verbal self-monitoring neural network and clinical insight in schizophrenia. Psychiatry Res 2015;234:328-35.
118. Bassitt DP, Neto MRL, de Castro CC et al. Insight and regional brain volumes in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2007;257:58-62.
119. David A, Van Os J, Jones P et al. Insight and psychotic illness. Crosssectional and longitudinal associations. Br J Psychiatry 1995;167:621-8.
120. Rossell S, Coakes J, Shapleske J et al. Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med 2003;33:111-9.
121. Hwang SS, Ahn YM, Kim YS. Neurocognitive functioning as an intermediary variable between psychopathology and insight in schizophrenia. Psychiatry Res 2015;230:792-9.
122. Diez-Martin J, Moreno-Ortega M, Bagney A et al. Differential relationships between set-shifting abilities and dimensions of insight in schizophrenia. Psychopathology 2014;47:86-92.
123. de Vos AE, Pijnenborg GH, Aleman A et al. Implicit and explicit selfrelated processing in relation to insight in patients with schizophrenia. Cogn Neuropsychiatry 2015;20:311-29.
124. Zaytseva Y, Korsakova N, Gurovich IY et al. Luria revisited: complex motor phenomena in first episode schizophrenia and schizophrenia spectrum disorders. Psychiatry Res 2014;220:145-51.
125. MacDougall AG, McKinnon MC, Herdman KA et al. The relationship between insight and autobiographical memory for emotional events in schizophrenia. Psychiatry Res 2015;226:392-5.
126. Bhagyavathi HD, Mehta UM, Thirthalli J et al. Cascading and combined effects of cognitive deficits and residual symptoms on functional outcome in schizophrenia – a path-analytical approach. Psychiatry Res2015;229:264-71.
127. Cernis E, Vassos E, Brebion G et al. Schizophrenia patients with high intelligence: a clinically distinct sub-type of schizophrenia? Eur Psychiatry 2015;30:628-32.
128. Gerretsen P, Plitman E, Raiji TK et al. The effects of aging on insight into illness in schizophrenia: a review. Int J Geriatr Psychiatry 2014;29:45-61.
129. Gerretsen P, Voineskos AN, Graff-Guerrero A et al. Insight into illness and cognition in schizophrenia in earlier and later life.
J Clin Psychiatry 2017; 150:217-22.
130. Gilleen J, David A, Greenwood K. Self-reflection and set-shifting mediate awareness in cognitively preserved schizophrenia patients. Cogn Neuropsychiatry 2016;21:185-96.
131. Aleman A, Agrawal N, Morgan KD et al. Insight in psychosis and neuropsychological function: meta-analysis. Br J Psychiatry 2006;189:204-12.
132. Nair A, Palmer EC, Aleman A et al. Relationship between cognition, clinical and cognitive insight in psychotic disorders: a review and meta-analysis. Schizophr Res 2014;152:191-200.
133. Kansal V, Patriciu I, Kiang M. Illness insight and neurophysiological error-processing deficits in schizophrenia. Schizophr Res 2014;156:122-7.
134. Poyraz BC, Arikan MK, Poyraz CA et al. Clinical and cognitive insight in patients with acute-phase psychosis: association with treatment and neuropsychological functioning. Nord J Psychiatry 2016;70:528-35.
135. Gonzalez-Blanch C, Alvarez-Jimenez M, Ayesa-Arriola R et al. Differential associations of cognitive insight components with pretreatment characteristics in first-episode psychosis. Psychiatry Res 2014;215:308-13.
136. Ohmuro N, Katsura M, Obara C et al. The relationship between cognitive insight and cognitive performance among individuals with at-risk mental state for developing psychosis. Schizophr Res (in press).
137. Brüne M. Theory of mind in schizophrenia: a review of the literature. Schizophr Bull 2005;31:21-42.
138. Green MF, Leitman DI. Social cognition in schizophrenia. Schizophr Bull 2008;34:670-2.
139. Vohs JL, George S, Leonhardt BL et al. An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments. Expert Rev Neurother 2016;16:
140. Ng R, Fish S, Granholm E. Insight and theory of mind in schizophrenia. Psychiatry Res 2015;225:169-74.
141. Popolo R, Dimaggio G, Luther L et al. Theory of mind in schizophrenia: associations with clinical and cognitive insight controlling for levels of psychopathology. J NervMent Dis 2016;204:
142. Bora E. Relationship between insight and theory of mind in schizophrenia: a meta-analysis. Schizophr Res (in press).
143. Flavell JH. Metacognition and cognitive monitoring: a new area of cognitive-developmental inquiry. Am Psychol 1979;34:906.
144. Lysaker PH, Vohs JL, Ballard R et al. Metacognition, self reflection and recovery in schizophrenia: review of the literature. Future Neurol 2013;8:103-15.
145. Lysaker PH, Vohs J, Minor K et al. Metacognitive deficits in schizophrenia: presence and associations with psychosocial outcomes. J Nerv Ment Dis 2015;203:530-6.
146. Bedford NJ, David AS. Denial of illness in schizophrenia as a disturbance of self-reflection, self-perception and insight. Schizophr Res 2014;152:89-96.
147. Moe AM, Breitborde NJ, Shakeel MK et al. Idea density in the life-stories of people with schizophrenia: associations with narrative qualities and psychiatric symptoms. Schizophr Res 2016;172:201-5.
148. Vidovic D, Brecic P, Vilibic M et al. Insight and self-stigma in patients with schizophrenia. Acta Clin Croat 2016;55:23-8.
149. Singh A, Mattoo SK, Grover S. Stigma and its correlates in patients with schizophrenia attending a general hospital psychiatric unit. Indian J Psychiatry 2016;58:291-300.
150. Drake RE, Whitley R. Recovery and severe mental illness: description and analysis. Can J Psychiatry 2014;59:236-42.
151. Karow A, Naber D, Lambert M et al. EGOFORS initiative: remission as perceived by people with schizophrenia, family members and psychiatrists. Eur Psychiatry 2012;27:426-31.
152. Slade M, Longden E. Empirical evidence about recovery and mental health. BMC Psychiatry 2015;15:1-14.
153. Ehrlich-Ben Or S, Hasson-Ohayon I, Feingold D et al. Meaning in life, insight and self-stigma among people with severe mental illness. Compr Psychiatry 2013;54:195-200.
154. Hasson-Ohayon I, Mashiach-Eizenberg M, Elhasid N et al. Between selfclarity and recovery in schizophrenia: reducing the self-stigma and finding meaning. Compr Psychiatry 2014;55:
155. Berg AO, Barrett EA, Nerhus M et al. Psychosis: clinical insight and beliefs in immigrants in their first episode. Early Interv Psychiatry (in press).
156. Mohamed S, Rosenheck R, He H et al. Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China. Soc Psychiatry Psychiatr Epidemiol 2014;49:1063-70.
157. Zisman-Ilani Y, Hasson-Ohayon I, Lev-Frank I et al. Self stigma, insight, and family burden among Israelimothers of people with serious mental illness: ethno-national considerations. Transcult Psychiatry 2017;54:423-41.
158. Macgregor A, Norton J, Bortolon C et al. Insight of patients and their parents into schizophrenia: exploring agreement and the influence of parental factors. Psychiatry Res 2015;228:879-86.
159. Raffard S, Bortolon C, Macgregor A et al. Cognitive insight in schizophrenia patients and their biological parents: a pilot study. Schizophr Res 2014;159:471-7.
160. Habib N, Dawood S, Kingdon D et al. Preliminary evaluation of culturally adapted CBT for psychosis (CA-CBTp): findings from developing culturally sensitive CBT project (DCCP). Behav Cogn Psychother 2015;43:200-8.
161. Li ZJ, Guo ZH, Wang N et al. Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychol Med 2015;45:1893-905.
162. Naeem F, Saeed S, Irfan M et al. Brief culturally adapted CBT for psychosis (CaCBTp): a randomized controlled trial from a low income country. Schizophr Res 2015;164:143-8.
163. Guo ZH, Li ZJ, Ma Y et al. Brief cognitive-behavioural therapy for patientsin the community with schizophrenia: randomised controlled trial in Beijing, China. Br J Psychiatry 2017;210:223-9.
164. Drake RJ, Day CJ, Picucci R et al. A naturalistic, randomized, controlled trial combining cognitive remediation with cognitive-behavioural therapy after first-episode non-affective psychosis. Psychol Med 2014;44:1889-99.
165. Chien WT, Muj JH, Cheung EF et al. Effects of motivational interviewing based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial. Trials 2015;16:1-14.
166. Chien WT, Muj J, Gray R et al. Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomized controlled trial. BMC Psychiatry 2016;16:1-14.
167. Chien WT, Thompson DR. Effects of a mindfulness-based psychoeducation programme for Chinese patients with schizophrenia: 2-year followup. Br J Psychiatry 2014;205:52-9.
168. Wang LQ, Chien WT, Yip LK et al. A randomized controlled trial of amindfulness-based intervention program for people with schizophrenia: 6-month follow-up. Neuropsychiatr Dis Treat 2016;12:3097-110.
169. Yilmaz E, Okanli A. Test of mindfulness-based psychosocial skills trainingto improve insight and functional recovery in schizophrenia. West J Nurs Res (in press).
170. Rakitzi S, Georgila P, Efthimiou K et al. Efficacy and feasibility of the integrated psychological therapy for outpatients with schizophrenia in Greece: final results of a RCT. Psychiatry Res 2016;242:137-43.
171. Zhou B, Gu Y. Effect of self-management training on adherence to medications among community residents with chronic schizophrenia: a single blind randomized controlled trial in Shanghai, China. Shanghai Arch Psychiatry 2014;26:332-8.
172. Jorgensen R, Licht RW, Lysaker PL et al. Effects on cognitive and clinical insight with the use of guided self-determination in outpatients with schizophrenia: a randomized open trial. Eur Psychiatry 2015;30:655-63.
173. Pijnenborg GH, Timmerman ME, Derks EM et al. Differential effects of antipsychotic drugs on insight in first episode schizophrenia: data from the European First-Episode Schizophrenia Trial (EUFEST). Eur Neuropsychopharmacol 2015;25:808-16.
174. Hou CL, Cai MY, Ma XR et al. Clozapine prescription and quality of life in Chinese patients with schizophrenia treated in primary care. Pharmacopsychiatry 2015;48:200-4.
175. Mattila T, Koeter M, Wohlfarth T. The impact of second generation antipsychotics on insight in schizophrenia: results from 14 randomized, placebocontrolled trials. Eur Neuropsychopharmacol 2017;27:82-6.
176. Moritz S, Andreou C, Schneider BC et al. Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia. Clin Psychol Rev 2014;34:358-66.
177. Balzan RP, Delfabbro PH, Galletly CA et al. Metacognitive training forpatients with schizophrenia: preliminary evidence for a targeted, single module programme. Aust N Z J Psychiatry 2014;48:1126-36.
178. Gaweda L, Krezolek M, Olbrys J et al. Decreasing self-reported cognitive biases and increasing clinical insight through meta-cognitive training inpatients with chronic schizophrenia. J Behav Ther Exp Psychiatry 2015;48:98-104.
179. Balzan RP, Galletly C. Metacognitive therapy (MCT1) in patients with psychosis not receiving antipsychotic medication: a case study. Front Psychol 2015;6:1-6.
180. Briki M, Monnin J, Haffen E et al. Metacognitive training for schizophrenia: a multicentre randomized controlled trial. Schizophr Res 2014;157:99-106.
181. Lam KC, Ho CP, Wa JC et al. Metacognitive training (MCT) for schizophrenia improves cognitive insight: a randomized controlled trial in a Chinese sample with schizophrenia spectrum disorders. Behav Res Ther 2015;64:38-42.
182. Ochoa S, Lopez-Carrilero R, Barrigon ML et al. Randomized control trialto assess the efficacy of metacognitive training compared with a psychoeducational group in people with a recent-onset psychosis. Psychol Med 2017;47:1573-84.
183. Ussorio D, Giusti L, Wittekind CE et al. Metacognitive training for young subjects (MCT young version) in the early stages of psychosis: is theduration of untreated psychosis a limiting factor? Psychol Psychother 2016;89:50-65.
184. van Oosterhout B, Krabbendam L, de Boer K et al. Metacognitive group training for schizophrenia spectrum patients with delusions: a randomized controlled trial. Psychol Med 2014;44:3025-35.
185. Lysaker PH, Klion RE. Recovery, meaning-making, and severe mental illness: a comprehensive guide to metacognitive reflection and insighttherapy. Abingdon-on-Thames: Routledge (in press).
186. Hamm JA, Firmin RL. Disorganization and individual psychotherapy for schizophrenia: a case report of metacognitive reflection and insight therapy. J Contemp Psychother 2016;46:227-34.
187. Leonhardt BL, Benson K, George S et al. Targeting insight in FEP: a case study of metacognitive reflection insight therapy (MERIT).
J Contemp Psychother 2016;46:207-16.
188. Leonhardt BL, Kukla M, Chadoin K et al. Emergence of psychotic content in psychotherapy: a qualitative analysis of content, process, and therapist variables. Psychother Res (in press).
189. Leonhardt BL, Ratliff K, Buck KD. Recovery in FEP: a case study of metacognitive reflection and insight therapy (MERIT). Am J Psychother (in press).
190. Vohs JL, Leonhardt BL, James AV et al. Metacognitive reflection and insight therapy for early psychosis: a preliminary study of a novel integrative psychotherapy. Schizophr Res (in press).
191. Connell M, Schweitzer R, King R. Recovery from first-episode psychosis and recovering self: a qualitative study. Psychiatr Rehabil
192. Jacob KS. Insight in psychosis: standards, science, ethics and value judgment. Int J Soc Psychiatry 2017;63:345-51.
193. Ogden LP. “My life as it has value”: narrating schizophrenia in later years. Qual Health Res 2014;24:1342-55.
194. Touskova T, Bob P. Consciousness, awareness of insight and neural mechanisms of schizophrenia. Rev Neurosci 2015;26:295-304.